<SEC-DOCUMENT>0000947871-18-000115-index.html : 20180212
<SEC-HEADER>0000947871-18-000115.hdr.sgml : 20180212
<ACCEPTANCE-DATETIME>20180212131703
ACCESSION NUMBER:		0000947871-18-000115
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20180212
DATE AS OF CHANGE:		20180212
GROUP MEMBERS:		ANDREW H. WARFORD
GROUP MEMBERS:		LEE S. AINSLIE III
GROUP MEMBERS:		MAVERICK CAPITAL MANAGEMENT, LLC

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMPAX LABORATORIES INC
		CENTRAL INDEX KEY:			0001003642
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				650403311
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-48867
		FILM NUMBER:		18595398

	BUSINESS ADDRESS:	
		STREET 1:		30831 HUNTWOOD AVENUE
		CITY:			HAYWARD
		STATE:			CA
		ZIP:			94544
		BUSINESS PHONE:		510-240-6000

	MAIL ADDRESS:	
		STREET 1:		30831 HUNTWOOD AVENUE
		CITY:			HAYWARD
		STATE:			CA
		ZIP:			94544

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GLOBAL PHARMACEUTICAL CORP \DE\
		DATE OF NAME CHANGE:	19951117

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MAVERICK CAPITAL LTD
		CENTRAL INDEX KEY:			0000934639
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			TX

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		300 CRESCENT COURT
		STREET 2:		18TH FLOOR
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201
		BUSINESS PHONE:		214.880.4050

	MAIL ADDRESS:	
		STREET 1:		300 CRESCENT COURT
		STREET 2:		18TH FLOOR
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>ss79101_13g.htm
<DESCRIPTION>SCHEDULE 13G
<TEXT>
Document 1 - file: ss79101_13g.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A
<SEQUENCE>2
<FILENAME>ss79101_ex99a.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
Document 2 - file: ss79101_ex99a.htm

</DOCUMENT>
</SEC-DOCUMENT>